Ratings
0
Nobody has rated this yet. Be the first!
Works
7
Abstract 5025: Immune expression profiling of MAPK inhibitor resistant tumors based upon mechanisms of resistance
BRAF inhibitor activity in V600R metastatic melanoma
Paradoxical oncogenesis: are all BRAF inhibitors equal?
Durability of response to immune checkpoint inhibitors (ICI) in metastatic Merkel cell carcinoma (mMCC) after treatment cessation.
Has the melanoma information tsunami become a maelstrom?
Abstract 2650: In depth immune profiling of the response of melanoma to MAPK inhibition
Neoadjuvant ipilimumab plus nivolumab in synchronous clinical stage III melanoma
